The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.
The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...
FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.
Hosted on MSN5d
Report Reveals Billions Made from Generic Drug Price HikesA recent Federal Trade Commission report highlights a concerning trend in the pharmaceutical industry, where pharmacy benefit managers (PBMs) are accused of significantly inflating the cost of ...
Shocking revelations from a Federal Trade Commission, or FTC, investigation have exposed how three major prescription benefit managers, or PBMs, ...
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
WQRF Rockford on MSN6d
Synders Pharmacy in Oregon closes drive-thru, says it can’t afford staffingSnyders Pharmacy, located in Oregon’s Ace Hardware, announced it has suspended operation of its drive-thru due to lack of ...
An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback